Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Cash: 2022-2025

Historic Change in Cash for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$17.4 million.

  • Gossamer Bio's Change in Cash rose 70.25% to -$17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.5 million, marking a year-over-year increase of 63.93%. This contributed to the annual value of $14.0 million for FY2024, which is 117.49% up from last year.
  • Per Gossamer Bio's latest filing, its Change in Cash stood at -$17.4 million for Q3 2025, which was down 540.71% from -$2.7 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Change in Cash registered a high of $59.2 million during Q3 2022, and its lowest value of -$58.4 million during Q3 2024.
  • Moreover, its 3-year median value for Change in Cash was -$17.1 million (2025), whereas its average is -$9.4 million.
  • As far as peak fluctuations go, Gossamer Bio's Change in Cash spiked by 270.03% in 2024, and later slumped by 352.49% in 2025.
  • Quarterly analysis of 4 years shows Gossamer Bio's Change in Cash stood at -$41.5 million in 2022, then declined by 21.68% to -$50.5 million in 2023, then soared by 134.87% to $17.6 million in 2024, then skyrocketed by 70.25% to -$17.4 million in 2025.
  • Its Change in Cash was -$17.4 million in Q3 2025, compared to -$2.7 million in Q2 2025 and -$17.1 million in Q1 2025.